The Effect of Autologous Protein Solution on the Inflammatory Cascade in Stimulated Equine Chondrocytes.
Authors: Linardi Renata L, Dodson Michael E, Moss Kaitlyn L, King William J, Ortved Kyla F
Journal: Frontiers in veterinary science
Summary
# Editorial Summary Cartilage damage in equine athletes frequently develops into post-traumatic osteoarthritis (PTOA), making the prevention of excessive inflammatory cascade critical to long-term joint health. Researchers isolated chondrocytes from six horses and exposed them to pro-inflammatory stimuli (IL-1β and TNF-α) whilst treating cultures with either autologous protein solution (APS) or autologous conditioned serum (ACS)—orthobiologic preparations that differ primarily in platelet inclusion—then measured concentrations of inflammatory mediators and protective cytokines using multiplex assay and ELISA. Both preparations elevated IL-1Ra (interleukin-1 receptor antagonist) without increasing IL-1β, but APS demonstrated superior chondroprotective potential, significantly increasing IL-1Ra and IL-10 (anti-inflammatory) whilst moderately elevating IL-6 (modulatory) in treated chondrocyte media after 48 hours. Notably, APS achieved these cytokine concentrations without requiring an incubation period—a practical advantage over ACS—suggesting APS may offer more rapid and effective dampening of the inflammatory milieu in acute joint injuries. For practitioners managing joint trauma in performance horses, these findings support APS as a rational choice for intra-articular treatment, though clinical outcome studies are needed to confirm whether this in vitro chondroprotective profile translates to improved healing and reduced PTOA development in vivo.
Read the full abstract on PubMed
Practical Takeaways
- •APS may offer faster anti-inflammatory effects than ACS in joint treatment since it requires no incubation time and immediately delivers high IL-1Ra concentrations
- •Both products appear to work by suppressing inflammatory signals rather than blocking cytokine production, suggesting complementary mechanisms with other therapies
- •In vitro results are promising but clinical efficacy in preventing PTOA remains to be demonstrated in controlled equine trials before changing treatment protocols
Key Findings
- •APS and ACS both significantly increased IL-1Ra concentrations without increasing IL-1β, suggesting anti-inflammatory potential
- •APS-treated chondrocyte cultures showed significantly elevated chondroprotective cytokines IL-1Ra and IL-10 after 48 hours
- •APS effectively concentrated IL-1Ra without requiring an incubation period, unlike ACS
- •APS induced increased IL-6 production, a modulatory cytokine that may support cartilage protection